Holen Sie sich die Stockscreener-App
1.32
2.33%
0.03
Vorhandelsmarkt:
1.33
0.01
+0.76%
Igm Biosciences Inc Aktie (IGMS) Neueste Nachrichten
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
IGM Biosciences price target lowered to $1 from $2 at Truist - Yahoo Finance
Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech
IGM Biosciences Faces Nasdaq Non-Compliance Notice - TipRanks
Truist Revises IGM Biosciences (IGMS) Price Target to $1 | IGMS Stock News - GuruFocus
Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating - MarketScreener
IGM Biosciences (NASDAQ:IGMS) Cut to "Sell" at Wall Street Zen - MarketBeat
Millennium Management LLC Sells 69,074 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
Two Sigma Investments LP Grows Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Rating Lowered to “Sell” at Wall Street Zen - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Stock Rating Upgraded by Wall Street Zen - MarketBeat
IGM Biosciences Reports Increased Net Loss Amid Strategic Focus - TipRanks
Wall Street Zen Upgrades IGM Biosciences (NASDAQ:IGMS) to “Hold” - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IGM Biosciences Terminates Headquarters Lease Agreement - TipRanks
IGM Biosciences, Inc. (NASDAQ:IGMS) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
IGM Biosciences earnings missed by $0.51, revenue fell short of estimates - Investing.com Canada
Sanofi Invests $8.79 Million in IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat
Rheumatoid Arthritis Market Anticipated to Expand Rapidly During 2024-2034, Says DelveInsight | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH - The Globe and Mail
IGM Biosciences’ SWOT analysis: biotech stock faces pivotal moment By Investing.com - Investing.com Nigeria
IGM Biosciences’ SWOT analysis: biotech stock faces pivotal moment - Investing.com
30,148 Shares in IGM Biosciences, Inc. (NASDAQ:IGMS) Bought by Cubist Systematic Strategies LLC - Defense World
IGM Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates - MSN
IGM Biosciences (IGMS) to Release Earnings on Wednesday - MarketBeat
IGM Biosciences (IGMS) to Release Quarterly Earnings on Wednesday - Defense World
IGM Biosciences says it is dropping development of imvotamab - The Pharma Letter
Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures - Fierce Biotech
IGM Biosciences ends agreement with Sanofi - Investing.com Australia
IGM Biosciences ends agreement with Sanofi By Investing.com - Investing.com South Africa
IGM Biosciences Ends Genzyme Collaboration, Cuts Workforce - TipRanks
Engineering an antibody against flu with sticky staying power - Ohio State News
Price T Rowe Associates Inc. MD Sells 445,260 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat
Renaissance Technologies LLC Raises Stock Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 1.5%Here's Why - MarketBeat
IGM Biosciences Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):